FDA Grants Breakthrough Designation for EvoLiver in HCC
EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.
Related Articles
Programme – BSH 2024
BSH 2024 will include the key pillars that have stood the programme in good stead for many years – outstanding plenary speakers, a wide range…
OncLive – Clinical Oncology News, Cancer Expert Insights
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Targeted Oncology – Immunotherapy, Biomarkers, and Cancer Pathways
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Welcome! You are invited to join a webinar: SSO & AAES & NANETS VTB: Multidisciplinary Management of Neuroendocrine Liver Metastases Virtual Tumor Board. After registering, you will receive a confirmation email about joining the webinar.
Welcome! You are invited to join a webinar: SSO & AAES & NANETS VTB: Multidisciplinary Management of Neuroendocrine Liver Metastases Virtual Tumor Board. After registering,…
Modifying Radioactive Injection Techniques May Decrease Extravasation Rate
A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.
Efficacy, Safety of Darolutamide and ADT in Black Men With mHSPC: ARANOTE Trial
Quoc-Dien Trinh, MD, MBA, discusses a sub-analysis of the phase 3 ARANOTE trial, focusing on Black patients with metastatic hormone-sensitive prostate cancer.
Proactive Patient Communication: Early Discussion on Salvage Therapies for Prostate Cancer
Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate cancer.
Keytruda Plus SOC: New Standard for Advanced Head & Neck Cancer
Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head and neck cancer per KEYNOTE-689, introducing a potential new standard of…
CA: A Cancer Journal for Clinicians Now Accepting Phase III Research
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and…
AACR Annual Meeting
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.